- Home
- RGNX vs NXRT Comparison
RGNX vs NXRT Comparison
Compare RGNX & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- NXRT
- Stock Information
- Founded
- RGNX 2008
- NXRT 2014
- Country
- RGNX United States
- NXRT United States
- Employees
- RGNX N/A
- NXRT N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- NXRT Real Estate Investment Trusts
- Sector
- RGNX Health Care
- NXRT Real Estate
- Exchange
- RGNX Nasdaq
- NXRT Nasdaq
- Market Cap
- RGNX 661.2M
- NXRT 776.2M
- IPO Year
- RGNX 2015
- NXRT N/A
- Fundamental
- Price
- RGNX $12.77
- NXRT $30.67
- Analyst Decision
- RGNX Strong Buy
- NXRT Hold
- Analyst Count
- RGNX 7
- NXRT 5
- Target Price
- RGNX $30.00
- NXRT $37.33
- AVG Volume (30 Days)
- RGNX 601.4K
- NXRT 166.0K
- Earning Date
- RGNX 11-06-2025
- NXRT 10-28-2025
- Dividend Yield
- RGNX N/A
- NXRT 6.91%
- EPS Growth
- RGNX N/A
- NXRT N/A
- EPS
- RGNX N/A
- NXRT N/A
- Revenue
- RGNX $155,782,000.00
- NXRT $253,196,000.00
- Revenue This Year
- RGNX $198.02
- NXRT N/A
- Revenue Next Year
- RGNX $2.67
- NXRT $3.72
- P/E Ratio
- RGNX N/A
- NXRT N/A
- Revenue Growth
- RGNX 74.95
- NXRT N/A
- 52 Week Low
- RGNX $5.04
- NXRT $29.93
- 52 Week High
- RGNX $13.93
- NXRT $48.31
- Technical
- Relative Strength Index (RSI)
- RGNX 58.75
- NXRT 44.47
- Support Level
- RGNX $12.66
- NXRT $29.93
- Resistance Level
- RGNX $13.93
- NXRT $31.44
- Average True Range (ATR)
- RGNX 0.72
- NXRT 0.81
- MACD
- RGNX -0.04
- NXRT -0.00
- Stochastic Oscillator
- RGNX 61.82
- NXRT 35.41
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.